Stock XOMAP XOMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus XOMA Corporation Nasdaq

Equities

XOMAP

US98419J3059

Market Closed - Nasdaq
Other stock markets
 21:30:01 17/05/2024 BST 		5-day change 1st Jan Change
25.02 USD -1.03% Intraday chart for XOMA Corporation -0.29% -1.54%
05-09 Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M MT
05-09 XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on XOMA Corporation

Price target over the last 5 years

History of analyst recommendation changes

7ba0105ab30fef6358cd9b38a5ee.WzN6apmVsWV5vcrsYTyjRa9NzluzGE-ImwM___v5xtA.CnIKJsDt5V0J97u8DGnaJJx-tzH1cjrv8Gl4vpmDooEzRTsw-6LzAS_7qQ~c8c71db7bb89df5d68c01eaf38cd8200

Analyst Recommendations on XOMA Corporation

Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target MT
HC Wainwright Adjusts Price Target on XOMA to $74 From $69, Maintains Buy Rating MT
XOMA : Wedbush Suspended Coverage on XOMA MT
XOMA : HC Wainwright Adjusts XOMA's Price Target to $69 from $56, Keeps Buy Rating MT
XOMA : Aegis Capital Adjusts XOMA Price Target to $56 From $60, Maintains Buy Rating MT
Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Aegis Capital Starts XOMA at Buy with $20.68 Price Target MT
XOMA : Wedbush Adjusts XOMA's Price Target to $41 From $36, Citing Iscalimab, Cetrelimab Projections; Outperform Rating Kept MT
XOMA : Wedbush Adjusts XOMA's Price Target to $36 From $29 on Vicineum Sales Forecast, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
25.51 USD
Average target price
58 USD
Spread / Average Target
+127.36%
High Price Target
74 USD
Spread / Highest target
+190.08%
Low Price Target
42 USD
Spread / Lowest Target
+64.64%

Consensus detail

Consensus revision (last 18 months)

Analysts covering XOMA Corporation

Leerink Partners
HC Wainwright
Wedbush
Aegis Capital

Ratings for XOMA Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XOMA Stock
  4. XOMAP Stock
  5. Consensus XOMA Corporation